Interestingly, our results demonstrated that hWJ-MSCs alleviate Con A-induced fulminant hepatitis primarily by suppressing hepatic CD3+ T cells with no significant change of macrophages, CD19+ B lymphocytes and NK1.1+ NK/NKT cells. The gene discussed is CD19; the disease is Fulminant hepatitis.